市場調査レポート
商品コード
1559320

ヒト成長ホルモンの世界市場、2024年~2028年

Global Human Growth Hormone Market 2024-2028


出版日
発行
TechNavio
ページ情報
英文 151 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ヒト成長ホルモンの世界市場、2024年~2028年
出版日: 2024年08月14日
発行: TechNavio
ページ情報: 英文 151 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒト成長ホルモン市場2024-2028

ヒト成長ホルモン市場は2023-2028年に9億4,910万米ドル、予測期間中のCAGRは4.5%で成長すると予測されます。当レポートでは、ヒト成長ホルモン市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、アドヒアランスを向上させるための長時間作用型および針を使用しないデリバリーの開拓、新たな適応症に対するヒト成長ホルモン補充療法のFDA承認、ヒト成長ホルモンの強力なパイプラインによって牽引されています。

市場範囲
基準年 2024
終了年 2028
予測期間 2024-2028
成長モメンタム 加速
前年比2024年 4.23%
CAGR 4.5%
増分額 9億4,910万米ドル

本調査では、今後数年間のヒト成長ホルモン市場成長を牽引する主な要因として、成長障害の発生率の増加を挙げています。また、バイオシミラーの市場参入の影響はなく、先端技術により、市場は大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第3章 市場規模の評価

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023
  • 市場の見通し 2023-2028

第4章 市場規模実績

  • ヒト成長ホルモンの世界市場 2018-2022
  • 用途別セグメント分析 2018-2022
  • 地域別セグメント分析 2018-2022
  • 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:用途別

  • 市場セグメンテーション
  • 比較:用途別
  • 成長ホルモン欠乏症:市場規模と予測 2023-2028
  • ISS:市場規模と予測 2023-2028
  • ターナー症候群:市場規模と予測 2023-2028
  • PWS:市場規模と予測 2023-2028
  • その他:市場規模と予測 2023-2028
  • 市場機会:用途別

第7章 顧客情勢

  • 顧客情勢の概要

第8章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023-2028
  • 欧州:市場規模と予測 2023-2028
  • アジア:市場規模と予測 2023-2028
  • 世界のその他の地域:市場規模と予測 2023-2028
  • 米国:市場規模と予測 2023-2028
  • デンマーク:市場規模と予測 2023-2028
  • 中国:市場規模と予測 2023-2028
  • カナダ:市場規模と予測 2023-2028
  • インド:市場規模と予測 2023-2028
  • 市場機会:地域情勢別

第9章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第10章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第11章 競合分析

  • 企業プロファイル
  • 企業の市場ポジショニング
  • Abbott Laboratories
  • Anhui Anke Biotechnology Group Co. Ltd.
  • Ascendis Pharma AS
  • F. Hoffmann La Roche Ltd.
  • Ferring BV
  • Ipsen Pharma
  • Merck and Co. Inc.
  • Novo Nordisk AS
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

第12章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Application
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Company Market Positioning
  • Exhibits9: Parent Market
  • Exhibits10: Data Table on - Parent Market
  • Exhibits11: Market characteristics analysis
  • Exhibits12: Value Chain Analysis
  • Exhibits13: Offerings of companies included in the market definition
  • Exhibits14: Market segments
  • Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Historic Market Size - Data Table on Global Human Growth Hormone Market 2018 - 2022 ($ million)
  • Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Application - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Application - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Application
  • Exhibits33: Data Table on Comparison by Application
  • Exhibits34: Chart on Growth hormone deficiency - Market size and forecast 2023-2028 ($ million)
  • Exhibits35: Data Table on Growth hormone deficiency - Market size and forecast 2023-2028 ($ million)
  • Exhibits36: Chart on Growth hormone deficiency - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Growth hormone deficiency - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on ISS - Market size and forecast 2023-2028 ($ million)
  • Exhibits39: Data Table on ISS - Market size and forecast 2023-2028 ($ million)
  • Exhibits40: Chart on ISS - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on ISS - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Turner syndrome - Market size and forecast 2023-2028 ($ million)
  • Exhibits43: Data Table on Turner syndrome - Market size and forecast 2023-2028 ($ million)
  • Exhibits44: Chart on Turner syndrome - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Turner syndrome - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Chart on PWS - Market size and forecast 2023-2028 ($ million)
  • Exhibits47: Data Table on PWS - Market size and forecast 2023-2028 ($ million)
  • Exhibits48: Chart on PWS - Year-over-year growth 2023-2028 (%)
  • Exhibits49: Data Table on PWS - Year-over-year growth 2023-2028 (%)
  • Exhibits50: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits51: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibits52: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits53: Data Table on Others - Year-over-year growth 2023-2028 (%)
  • Exhibits54: Market opportunity by Application ($ million)
  • Exhibits55: Data Table on Market opportunity by Application ($ million)
  • Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits57: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits58: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits59: Chart on Geographic comparison
  • Exhibits60: Data Table on Geographic comparison
  • Exhibits61: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits62: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits63: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits66: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits67: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits68: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits70: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits72: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits74: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits75: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits76: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits78: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits79: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on Denmark - Market size and forecast 2023-2028 ($ million)
  • Exhibits82: Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
  • Exhibits83: Chart on Denmark - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on Denmark - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on India - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on India - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on India - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Market opportunity By Geographical Landscape ($ million)
  • Exhibits98: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits99: Impact of drivers and challenges in 2023 and 2028
  • Exhibits100: Overview on criticality of inputs and factors of differentiation
  • Exhibits101: Overview on factors of disruption
  • Exhibits102: Impact of key risks on business
  • Exhibits103: Companies covered
  • Exhibits104: Matrix on companies position and classification
  • Exhibits105: Abbott Laboratories - Overview
  • Exhibits106: Abbott Laboratories - Business segments
  • Exhibits107: Abbott Laboratories - Key news
  • Exhibits108: Abbott Laboratories - Key offerings
  • Exhibits109: Abbott Laboratories - Segment focus
  • Exhibits110: Anhui Anke Biotechnology Group Co. Ltd. - Overview
  • Exhibits111: Anhui Anke Biotechnology Group Co. Ltd. - Product / Service
  • Exhibits112: Anhui Anke Biotechnology Group Co. Ltd. - Key offerings
  • Exhibits113: Ascendis Pharma AS - Overview
  • Exhibits114: Ascendis Pharma AS - Product / Service
  • Exhibits115: Ascendis Pharma AS - Key offerings
  • Exhibits116: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits117: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits118: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits119: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits120: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits121: Ferring BV - Overview
  • Exhibits122: Ferring BV - Product / Service
  • Exhibits123: Ferring BV - Key news
  • Exhibits124: Ferring BV - Key offerings
  • Exhibits125: Ipsen Pharma - Overview
  • Exhibits126: Ipsen Pharma - Business segments
  • Exhibits127: Ipsen Pharma - Key offerings
  • Exhibits128: Ipsen Pharma - Segment focus
  • Exhibits129: Merck and Co. Inc. - Overview
  • Exhibits130: Merck and Co. Inc. - Business segments
  • Exhibits131: Merck and Co. Inc. - Key news
  • Exhibits132: Merck and Co. Inc. - Key offerings
  • Exhibits133: Merck and Co. Inc. - Segment focus
  • Exhibits134: Novo Nordisk AS - Overview
  • Exhibits135: Novo Nordisk AS - Business segments
  • Exhibits136: Novo Nordisk AS - Key news
  • Exhibits137: Novo Nordisk AS - Key offerings
  • Exhibits138: Novo Nordisk AS - Segment focus
  • Exhibits139: Pfizer Inc. - Overview
  • Exhibits140: Pfizer Inc. - Product / Service
  • Exhibits141: Pfizer Inc. - Key news
  • Exhibits142: Pfizer Inc. - Key offerings
  • Exhibits143: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits144: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits145: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits146: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits147: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits148: Inclusions checklist
  • Exhibits149: Exclusions checklist
  • Exhibits150: Currency conversion rates for US$
  • Exhibits151: Research methodology
  • Exhibits152: Information sources
  • Exhibits153: Data validation
  • Exhibits154: Validation techniques employed for market sizing
  • Exhibits155: Data synthesis
  • Exhibits156: 360 degree market analysis
  • Exhibits157: List of abbreviations
目次
Product Code: IRTNTR73043

Human Growth Hormone Market 2024-2028

The human growth hormone market is forecasted to grow by USD 949.1 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the human growth hormone market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by development of long-acting and needle-free deliveries to improve adherence, fda approval of human growth hormone replacement therapy for new indications, and strong pipeline of human growth hormones.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20244.23%
CAGR4.5%
Incremental Value$949.1 mn

Technavio's human growth hormone market is segmented as below:

By Application

    • Growth hormone deficiency
    • ISS
    • Turner syndrome
    • PWS
    • Others

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the increasing incidence of growth disorders as one of the prime reasons driving the human growth hormone market growth during the next few years. Also, no impact of biosimilar entry into market and advanced technologies will lead to sizable demand in the market.

The report on the human growth hormone market covers the following areas:

    • Human growth hormone market sizing
    • Human growth hormone market forecast
    • Human growth hormone market industry analysis

The vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human growth hormone market vendors that include Abbott Laboratories, Aeterna Zentaris Inc., Anhui Anke Biotechnology Group Co. Ltd., Ascendis Pharma AS, F. Hoffmann La Roche Ltd., Ferring BV, Ipsen Pharma, LG Chem Ltd., Merck and Co. Inc., Novo Nordisk AS, Pfizer Inc., Sandoz Group AG, Teva Pharmaceutical Industries Ltd., Xeris Biopharma Holdings Inc., and Zhongshan Sinobioway Hygene Biomedicine Co. Ltd.. Also, the human growth hormone market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The comapniespresents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Human Growth Hormone Market 2018 - 2022
    • Historic Market Size - Data Table on Global Human Growth Hormone Market 2018 - 2022 ($ million)
  • 4.2 Application segment analysis 2018 - 2022
    • Historic Market Size - Application Segment 2018 - 2022 ($ million)
  • 4.3 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.4 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

  • 6.1 Market segments
    • Chart on Application - Market share 2023-2028 (%)
    • Data Table on Application - Market share 2023-2028 (%)
  • 6.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 6.3 Growth hormone deficiency - Market size and forecast 2023-2028
    • Chart on Growth hormone deficiency - Market size and forecast 2023-2028 ($ million)
    • Data Table on Growth hormone deficiency - Market size and forecast 2023-2028 ($ million)
    • Chart on Growth hormone deficiency - Year-over-year growth 2023-2028 (%)
    • Data Table on Growth hormone deficiency - Year-over-year growth 2023-2028 (%)
  • 6.4 ISS - Market size and forecast 2023-2028
    • Chart on ISS - Market size and forecast 2023-2028 ($ million)
    • Data Table on ISS - Market size and forecast 2023-2028 ($ million)
    • Chart on ISS - Year-over-year growth 2023-2028 (%)
    • Data Table on ISS - Year-over-year growth 2023-2028 (%)
  • 6.5 Turner syndrome - Market size and forecast 2023-2028
    • Chart on Turner syndrome - Market size and forecast 2023-2028 ($ million)
    • Data Table on Turner syndrome - Market size and forecast 2023-2028 ($ million)
    • Chart on Turner syndrome - Year-over-year growth 2023-2028 (%)
    • Data Table on Turner syndrome - Year-over-year growth 2023-2028 (%)
  • 6.6 PWS - Market size and forecast 2023-2028
    • Chart on PWS - Market size and forecast 2023-2028 ($ million)
    • Data Table on PWS - Market size and forecast 2023-2028 ($ million)
    • Chart on PWS - Year-over-year growth 2023-2028 (%)
    • Data Table on PWS - Year-over-year growth 2023-2028 (%)
  • 6.7 Others - Market size and forecast 2023-2028
    • Chart on Others - Market size and forecast 2023-2028 ($ million)
    • Data Table on Others - Market size and forecast 2023-2028 ($ million)
    • Chart on Others - Year-over-year growth 2023-2028 (%)
    • Data Table on Others - Year-over-year growth 2023-2028 (%)
  • 6.8 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

7 Customer Landscape

  • 7.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

  • 8.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 8.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 8.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 8.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 8.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 8.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 8.8 Denmark - Market size and forecast 2023-2028
    • Chart on Denmark - Market size and forecast 2023-2028 ($ million)
    • Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
    • Chart on Denmark - Year-over-year growth 2023-2028 (%)
    • Data Table on Denmark - Year-over-year growth 2023-2028 (%)
  • 8.9 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 8.10 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 8.11 India - Market size and forecast 2023-2028
    • Chart on India - Market size and forecast 2023-2028 ($ million)
    • Data Table on India - Market size and forecast 2023-2028 ($ million)
    • Chart on India - Year-over-year growth 2023-2028 (%)
    • Data Table on India - Year-over-year growth 2023-2028 (%)
  • 8.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

  • 9.1 Market drivers
  • 9.2 Market challenges
  • 9.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 9.4 Market opportunities/restraints

10 Competitive Landscape

  • 10.1 Overview
  • 10.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 10.3 Landscape disruption
    • Overview on factors of disruption
  • 10.4 Industry risks
    • Impact of key risks on business

11 Competitive Analysis

  • 11.1 Companies profiled
    • Companies covered
  • 11.2 Market positioning of companies
    • Matrix on companies position and classification
  • 11.3 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
  • 11.4 Anhui Anke Biotechnology Group Co. Ltd.
    • Anhui Anke Biotechnology Group Co. Ltd. - Overview
    • Anhui Anke Biotechnology Group Co. Ltd. - Product / Service
    • Anhui Anke Biotechnology Group Co. Ltd. - Key offerings
  • 11.5 Ascendis Pharma AS
    • Ascendis Pharma AS - Overview
    • Ascendis Pharma AS - Product / Service
    • Ascendis Pharma AS - Key offerings
  • 11.6 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
  • 11.7 Ferring BV
    • Ferring BV - Overview
    • Ferring BV - Product / Service
    • Ferring BV - Key news
    • Ferring BV - Key offerings
  • 11.8 Ipsen Pharma
    • Ipsen Pharma - Overview
    • Ipsen Pharma - Business segments
    • Ipsen Pharma - Key offerings
    • Ipsen Pharma - Segment focus
  • 11.9 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
  • 11.10 Novo Nordisk AS
    • Novo Nordisk AS - Overview
    • Novo Nordisk AS - Business segments
    • Novo Nordisk AS - Key news
    • Novo Nordisk AS - Key offerings
    • Novo Nordisk AS - Segment focus
  • 11.11 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
  • 11.12 Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd. - Overview
    • Teva Pharmaceutical Industries Ltd. - Business segments
    • Teva Pharmaceutical Industries Ltd. - Key news
    • Teva Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd. - Segment focus

12 Appendix

  • 12.1 Scope of the report
  • 12.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 12.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 12.4 Research methodology
    • Research methodology
  • 12.5 Data procurement
    • Information sources
  • 12.6 Data validation
    • Data validation
  • 12.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 12.8 Data synthesis
    • Data synthesis
    • 360 degree market analysis
    • 360 degree market analysis
  • 12.10 List of abbreviations
    • List of abbreviations